These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6530478)
21. High-performance liquid chromatographic determination of amezinium in human plasma. Hotz D; Brode E J Chromatogr; 1983 Oct; 277():217-27. PubMed ID: 6643607 [TBL] [Abstract][Full Text] [Related]
22. [Determination of enoximone and its principle metabolite in serum and urine using high pressure liquid chromatography]. Tarral E; Jehl F; Gallion C; Monteil H Therapie; 1990; 45(1):1-6. PubMed ID: 2140472 [TBL] [Abstract][Full Text] [Related]
23. [Solid phase clean-up and determination of vesnarinone in plasma by high performance liquid chromatography]. Wu S; Wu C Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):106-9. PubMed ID: 1398618 [TBL] [Abstract][Full Text] [Related]
24. High-performance liquid chromatographic determination of cadralazine in human plasma and urine. Emilsson H J Chromatogr; 1988 Jan; 424(1):119-28. PubMed ID: 3366823 [TBL] [Abstract][Full Text] [Related]
25. Determination of the antiallergenic agent, N-[4-(1H-imidazol-1-yl)butyl]-2-(1-methylethyl)-11-oxo-11H- pyrido [2,1-b]quinazoline-8-carboxamide, in plasma by reversed-phase high-performance liquid chromatographic analysis using fluorometric detection. Strojny N; Puglisi CV; de Silva JA J Chromatogr; 1984 Dec; 336(2):301-11. PubMed ID: 6530462 [TBL] [Abstract][Full Text] [Related]
26. Determination of saterinone in plasma by high-performance liquid chromatography. Rudolph M J Chromatogr; 1989 Dec; 497():342-8. PubMed ID: 2625472 [No Abstract] [Full Text] [Related]
27. Determination of cadralazine in human plasma and urine by high-performance liquid chromatography. Hauffe SA; Dubois JP J Chromatogr; 1984 May; 290():223-30. PubMed ID: 6736162 [TBL] [Abstract][Full Text] [Related]
29. Multiple inverse isotope dilution assay for cadralazine and four metabolites in biological fluids. Schütz H; Faigle JW J Chromatogr; 1983 Dec; 281():273-80. PubMed ID: 6365939 [TBL] [Abstract][Full Text] [Related]
30. Determination of saterinone enantiomers in plasma samples with an internal standard using a Chiralcel OD column, fractionation and reversed-phase chromatography. Rudolph M; Volk D; Schmiedel G J Chromatogr; 1990 Dec; 535(1-2):263-9. PubMed ID: 2089055 [TBL] [Abstract][Full Text] [Related]
31. High-performance liquid chromatographic method for the determination of adibendan in plasma and urine. Reiff K J Chromatogr; 1987 Nov; 422():346-52. PubMed ID: 3437024 [No Abstract] [Full Text] [Related]
32. Quantitation of a new hypoglycaemic drug, 2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate (DG-5128), in plasma by gas chromatography-mass spectrometry. Nakaoka M; Ohtani A; Hakusui H J Chromatogr; 1986 Jun; 378(2):467-72. PubMed ID: 3734003 [No Abstract] [Full Text] [Related]
33. Analysis of 5-(4-acetamidophenyl)pyrazin-2(1H)-one (SK&F 94120) in plasma with an Analytichem automated sample processor liquid chromatography module. Pearce JC; Jelly JA; Fernandes KA; Leavens WJ; McDowall RD J Chromatogr; 1986 Feb; 353():371-8. PubMed ID: 3700521 [TBL] [Abstract][Full Text] [Related]
34. Reversed-phase high-performance liquid chromatographic assay for the antineoplastic agent 9,10-anthracenedicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl hydrazone) dihydrochloride. Powis G J Chromatogr; 1981 Dec; 226(2):514-20. PubMed ID: 7320182 [No Abstract] [Full Text] [Related]
35. Effects of MCI-154, a new cardiotonic Ca2+ sensitizer, on ventricular arrhythmias and membrane ionic currents. Eto K; Xue YX; Hashimoto K Eur J Pharmacol; 1996 Mar; 298(3):247-56. PubMed ID: 8846823 [TBL] [Abstract][Full Text] [Related]
36. A sensitive high performance liquid chromatography microassay for bemoradan, a novel cardiotonic agent, in plasma/serum using a semi-automatic liquid/solid extraction sample preparation system--AASP. Huang SM; Chien SC; Flor SC Biomed Chromatogr; 1990 Mar; 4(2):52-5. PubMed ID: 2350597 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties. Narimatsu A; Kitada Y; Satoh N; Suzuki R; Okushima H Arzneimittelforschung; 1987 Apr; 37(4):398-406. PubMed ID: 3606694 [TBL] [Abstract][Full Text] [Related]
38. High-performance liquid chromatographic determination of milrinone in biological tissues and fluids. Verrijk R; van Rooij HH; Wemer J; Porsius AJ J Chromatogr; 1989 Jun; 491(1):265-8. PubMed ID: 2793979 [No Abstract] [Full Text] [Related]
39. Effect on contractility of skinned fibres from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methy l-3(2H )- pyridazinone. Rüegg JC; Pfitzer G; Eubler D; Zeugner C Arzneimittelforschung; 1984; 34(12):1736-8. PubMed ID: 6543308 [TBL] [Abstract][Full Text] [Related]
40. Quantitative determination of cardiotonic agent MDL 17,043 in plasma by reversed-phase high-performance liquid chromatography. Chan KY; Lang JF; Okerholm RA J Chromatogr; 1983 Feb; 272(2):396-400. PubMed ID: 6220024 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]